FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $45,953 | +76.4% | 12,287 | 0.0% | 0.00% | +100.0% |
| Q3 2023 | $26,048 | -76.9% | 12,287 | -48.0% | 0.00% | -75.0% |
| Q2 2023 | $112,545 | +60.7% | 23,644 | +92.4% | 0.00% | +33.3% |
| Q1 2023 | $70,035 | +56379.8% | 12,287 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $124 | -100.0% | 12,287 | +5.3% | 0.01% | -58.3% |
| Q3 2022 | $262,000 | -12.4% | 11,672 | -3.2% | 0.01% | -7.7% |
| Q2 2022 | $299,000 | -36.0% | 12,058 | 0.0% | 0.01% | -18.8% |
| Q1 2022 | $467,000 | -33.9% | 12,058 | 0.0% | 0.02% | -30.4% |
| Q4 2021 | $706,000 | +5.4% | 12,058 | +6.7% | 0.02% | -4.2% |
| Q3 2021 | $670,000 | -31.7% | 11,304 | 0.0% | 0.02% | -31.4% |
| Q2 2021 | $981,000 | +121.9% | 11,304 | +110.9% | 0.04% | +105.9% |
| Q1 2021 | $442,000 | – | 5,361 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |